About Partners Intelligence Log in →
Connecting Israeli Defense Tech to US Needs
Log in

TytoCare

FDA-cleared handheld remote-exam device with AI diagnostics (Home Smart Clinic)

Israel
201-500

Latest event found: 15 Jul 2026 · 3 months ago

Vitality Radar

41
Current
6M History
Industry
Updated 7 days ago

Pillar Analysis

Presence
The analyst’s view of digital footprint. Shown for context; not part of the score.
82
Business
Dated funding, customer wins, partnerships and acquisitions made, less down rounds, litigation and regulatory action.
55
Innovation
Dated product launches and regulatory clearances, less products retired.
33
Pulse
Direction: dated events in the last 90 days against the 90 before. 50 is flat.
57
Capacity
Dated hiring, leadership hires, expansion and certifications, less layoffs, departures and closures.
0

Strategic Assessment

Strategic Vector

TytoCare is accelerating toward an AI-first remote diagnostics platform through regulatory expansion, major payer and health-system integrations, and international commercialization. The July 2026 CEO transition and growth financing indicate renewed scaling ambition, although reported workforce reductions suggest execution pressure during the transition.

Efficiency Ratio

The company is converting substantial financing and a mid-sized workforce into strong regulatory, product, and partnership output, but reported layoffs indicate improving capital discipline or restructuring needs.

Evidence Signals

1 negative signal
Leadership Hire MEDIUM IMPACT LOW CONF 15 Jul 2026

TytoCare appointed Adam Pellegrini as chief executive officer while former CEO Gilad Paz transitioned to chairman.

View source United States
Funding HIGH IMPACT LOW CONF 15 Jul 2026

TytoCare closed an oversubscribed growth financing of more than $25 million led by Insight Partners, with participation from HOOP, OliveTree, OrbiMed, Qumra Capital, Qualcomm Ventures, and other investors.

View source United States
Regulatory Clearance HIGH IMPACT LOW CONF 27 Apr 2026

The FDA granted De Novo classification to Tyto Insights ENT Suite for AI-powered analysis of otoscopic eardrum video recordings.

View source United States
Partnership HIGH IMPACT LOW CONF 18 Nov 2025

TytoCare announced integration of Home Smart Clinic with Teladoc Health 24/7 Care and Primary360 programs, with rollout to select customers planned during 2026.

View source United States

Background · older than 12 months

Product Launch MEDIUM IMPACT LOW CONF 15 Oct 2025

TytoCare unveiled an AI-powered Smart Clinic Companion based on its multimodal health dataset, with design-partner and beta releases planned for the fourth quarter of 2025 and broader rollout beginning in February 2026.

View source United States
Layoffs HIGH IMPACT HIGH CONF 9 Oct 2025

Calcalist reported that TytoCare cut 20% of its staff and that CEO Gilad Paz would transition to chairman; the available search result does not provide the specific event date.

View source Israel

About
Israeli telehealth company (co-headquartered in Netanya, Israel and New York), founded in 2012 by Dedi Gilad and Ofer Tzadik. Makes the FDA- and CE-cleared Home Smart Clinic — a handheld remote examination device (stethoscope, otoscope, camera, thermometer covering heart, lungs, ears, throat, skin, abdomen) paired with Tyto Insights AI-powered guidance and diagnostics — enabling clinic-quality remote physical exams from home or field. Partners with 200+ health systems and plans worldwide; its devices were used at Sheba Medical Center's field hospital in Ukraine to let physicians in Israel remotely examine patients, a direct austere/field-medicine proof point. Maps to the combat-telemedicine / tele-mentorship thread of C12-03; defense relevance is commercial-first but field-validated.
Tags
#telemedicine #remoteexam #homesmartclinic #fda #ai #telehealth #stethoscope #fieldhospital

Suggest an edit

Footer

Connecting Israeli Defense Tech to US Needs

Powered by Meschonomy

Terms Privacy Contact